Form 4 for GRDX GridAI Technologies Corp.
Accepted 2024-01-03 00:00:00 ET · period of report 2023-12-29 · accession 0001104659-24-001026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-01-03 | 2023-12-29+ | GRDX | SAPIRSTEIN JAMES | COB, Pres, CEO, Dir | A - Grant | $0.00 | +37.7K | 39.3K | +2,252% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-29 | A | A | 17,660 | $0.00 | 19,332 | D | — | — | (F1) On December 29, 2023, the Reporting Person was granted 17,660 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest upon closing of the Issuer's proposed acquisition of ImmunogenX, Inc. (F3) Includes unvested RSUs. |
| 2 | Common | Common Stock | 2024-01-02 | A | A | 20,000 | $0.00 | 39,332 | D | — | — | (F2) On January 2, 2024, the Reporting Person was granted 20,000 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest quarterly for one year with 25% vesting quarterly beginning April 1, 2024. (F3) Includes unvested RSUs. |